PTC Therapeutics, Inc. (NASDAQ: PTCT) today provided an update on the Company's progress and its outlook for 2026. Matthew B. Klein, M.D., Chief Executive Officer of PTC, will discuss these updates at ...
TipRanks on MSN
PTC Therapeutics fully monetizes Evrysdi royalty interest
PTC Therapeutics ( ($PTCT) ) has shared an update. On December 29, 2025, PTC Therapeutics, Inc. entered into a second amendment to its Amended and ...
Founded in 1985, the Boston, Massachusetts-based PTC Inc. (PTC) provides software solutions and services globally that aid ...
PTC (NASDAQ: PTC) has outperformed the market over the past 10 years by 7.24% on an annualized basis producing an average annual return of 20.37%. Currently, PTC has a market capitalization of $24.39 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback